Molecular and Cellular Biology, September 2006, p. 6727-6738, Vol. 26, No. 17
0270-7306/06/$08.00+0 doi:10.1128/MCB.00688-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.
Stephen J. Simmonds,1
Nicholas G. Clarkson,1
Sarah Hanrahan,2
Michael J. Puklavec,1
Martine Bomb,1
A. Neil Barclay,1 and
Marion H. Brown1*
Sir William Dunn School of Pathology, South Parks Rd., Oxford, United Kingdom,1 Cancer Research UK London Research Institute, Lincoln's Inn Fields Laboratories, London, United Kingdom2
Received 21 April 2006/ Accepted 6 June 2006
Deciphering the role of lymphocyte membrane proteins depends on dissecting the role of a protein in the steady state and on engagement with its ligand. We show that expression of CD6 in T cells limits their responsiveness but that engagement by the physiological ligand CD166 gives costimulation. This costimulatory effect of CD6 is mediated through phosphorylation-dependent binding of a specific tyrosine residue, 662Y, in its cytoplasmic region to the adaptor SLP-76. A direct interaction between SLP-76 and CD6 was shown by binding both to a phosphorylated peptide (equilibrium dissociation constant [KD] = 0.5 µM at 37°C) and, using a novel approach, to native phosphorylated CD6. Evidence that CD6 and SLP-76 interact in cells was obtained in coprecipitation experiments with normal human T cells. Analysis of human CD6 mutants in a murine T-cell hybridoma model showed that both costimulation by CD6 and the interaction between CD6 and SLP-76 were dependent on 662Y. The results have implications for regulation by CD6 and the related T-cell surface protein, CD5.
Present address: GlaxoSmithKline, Harlow, United Kingdom.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»